annual ROE:
-231.63%-72.42%(-45.49%)Summary
- As of today (August 22, 2025), AXSM annual return on equity is -231.63%, with the most recent change of -72.42% (-45.49%) on December 31, 2024.
- During the last 3 years, AXSM annual ROE has fallen by -30.12% (-14.95%).
- AXSM annual ROE is now -223.62% below its all-time high of 187.37%, reached on December 31, 2014.
Performance
AXSM ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-325.69%-16.50%(-5.34%)Summary
- As of today (August 22, 2025), AXSM quarterly return on equity is -325.69%, with the most recent change of -16.50% (-5.34%) on June 30, 2025.
- Over the past year, AXSM quarterly ROE has dropped by -169.25% (-108.19%).
- AXSM quarterly ROE is now -168.39% below its all-time high of 476.20%, reached on September 30, 2015.
Performance
AXSM quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AXSM ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.5% | -108.2% |
| 3 y3 years | -14.9% | +30.6% |
| 5 y5 years | -204.5% | -257.6% |
AXSM ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.5% | +22.5% | -199.2% | +30.6% |
| 5 y | 5-year | -229.2% | +22.5% | -367.3% | +30.6% |
| alltime | all time | -223.6% | +34.0% | -168.4% | +38.5% |
AXSM ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -325.69%(+5.3%) |
| Mar 2025 | - | -309.19%(+26.6%) |
| Dec 2024 | -231.63%(+45.5%) | -244.32%(+25.8%) |
| Sep 2024 | - | -194.28%(+24.2%) |
| Jun 2024 | - | -156.44%(+5.1%) |
| Mar 2024 | - | -148.91%(+19.6%) |
| Dec 2023 | -159.21%(-46.7%) | -124.52%(+14.4%) |
| Sep 2023 | - | -108.86%(-20.6%) |
| Jun 2023 | - | -137.09%(-29.4%) |
| Mar 2023 | - | -194.21%(-35.1%) |
| Dec 2022 | -298.97%(+48.4%) | -299.47%(-8.0%) |
| Sep 2022 | - | -325.46%(-30.7%) |
| Jun 2022 | - | -469.46%(+60.6%) |
| Mar 2022 | - | -292.34%(+52.4%) |
| Dec 2021 | -201.51%(+186.4%) | -191.84%(+40.4%) |
| Sep 2021 | - | -136.66%(+37.3%) |
| Jun 2021 | - | -99.50%(+30.9%) |
| Mar 2021 | - | -76.00%(+9.0%) |
| Dec 2020 | -70.36%(-7.5%) | -69.70%(-10.7%) |
| Sep 2020 | - | -78.06%(-14.3%) |
| Jun 2020 | - | -91.07%(-22.6%) |
| Mar 2020 | - | -117.63%(-21.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | -76.08%(-78.3%) | -149.79%(-71.7%) |
| Sep 2019 | - | -529.66%(+26.1%) |
| Jun 2019 | - | -419.91%(-11.8%) |
| Mar 2019 | - | -476.08%(+16.8%) |
| Dec 2018 | -350.78%(+132.0%) | -407.52%(+52.5%) |
| Sep 2018 | - | -267.18%(+50.5%) |
| Jun 2018 | - | -177.53%(+35.4%) |
| Mar 2018 | - | -131.16%(-2.9%) |
| Dec 2017 | -151.19%(+89.0%) | -135.04%(+11.1%) |
| Sep 2017 | - | -121.56%(+12.3%) |
| Jun 2017 | - | -108.28%(+14.6%) |
| Mar 2017 | - | -94.51%(+19.8%) |
| Dec 2016 | -79.99%(+41.6%) | -78.92%(+37.8%) |
| Sep 2016 | - | -57.27%(-4.5%) |
| Jun 2016 | - | -59.98%(-11.4%) |
| Mar 2016 | - | -67.73%(-7.8%) |
| Dec 2015 | -56.48%(-130.1%) | -73.44%(-115.4%) |
| Sep 2015 | - | 476.20%(+312.5%) |
| Jun 2015 | - | 115.45%(-4.8%) |
| Mar 2015 | - | 121.23%(+122.8%) |
| Dec 2014 | 187.37%(+74.9%) | 54.41% |
| Dec 2013 | 107.11% | - |
FAQ
- What is Axsome Therapeutics, Inc. annual return on equity?
- What is the all time high annual ROE for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. annual ROE year-on-year change?
- What is Axsome Therapeutics, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. quarterly ROE year-on-year change?
What is Axsome Therapeutics, Inc. annual return on equity?
The current annual ROE of AXSM is -231.63%
What is the all time high annual ROE for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high annual return on equity is 187.37%
What is Axsome Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, AXSM annual return on equity has changed by -72.42% (-45.49%)
What is Axsome Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of AXSM is -325.69%
What is the all time high quarterly ROE for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high quarterly return on equity is 476.20%
What is Axsome Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, AXSM quarterly return on equity has changed by -169.25% (-108.19%)